Healthcare provider profile · identity verified

Matthew C Monteiro, MD

Family Practice · SHOREVIEW, MN · NPI 1285640235

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	667	172
Amlodipine Besylate	Amlodipine Besylate	475	130
Rosuvastatin Calcium	Rosuvastatin Calcium	447	129
Losartan Potassium	Losartan Potassium	439	124
Lisinopril	Lisinopril	374	110
Levothyroxine Sodium	Levothyroxine Sodium	307	73
Metoprolol Succinate	Metoprolol Succinate	274	84
Hydrochlorothiazide	Hydrochlorothiazide	217	62
Metformin Hcl	Metformin Hcl	195	47
Omeprazole	Omeprazole	188	51
Pravastatin Sodium	Pravastatin Sodium	187	49
Simvastatin	Simvastatin	159	43
Tamsulosin Hcl	Tamsulosin Hcl	156	50
Gabapentin	Gabapentin	151	39
Trazodone Hcl	Trazodone Hcl	145	44
Escitalopram Oxalate	Escitalopram Oxalate	133	39
Eliquis	Apixaban	121	28
Metformin Hcl Er	Metformin Hcl	114	29
Furosemide	Furosemide	106	40
Metoprolol Tartrate	Metoprolol Tartrate	102	34
Atenolol	Atenolol	99	24
Carvedilol	Carvedilol	99	26
Jardiance	Empagliflozin	95	22
Glipizide Er	Glipizide	80	16
Albuterol Sulfate Hfa	Albuterol Sulfate	76	36
Prednisone	Prednisone	73	47
Sertraline Hcl	Sertraline Hcl	69	21
Irbesartan	Irbesartan	68	18
Citalopram Hbr	Citalopram Hydrobromide	67	15
Famotidine	Famotidine	67	14
Warfarin Sodium	Warfarin Sodium	62	17
Allopurinol	Allopurinol	60	20
Xarelto	Rivaroxaban	60	18
Januvia	Sitagliptin Phosphate	57	13
Duloxetine Hcl	Duloxetine Hcl	56	18
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	50	14
Oxycodone Hcl	Oxycodone Hcl	46	12
Ezetimibe	Ezetimibe	45	14
Buspirone Hcl	Buspirone Hcl	43	suppressed
Pantoprazole Sodium	Pantoprazole Sodium	43	15
Alendronate Sodium	Alendronate Sodium	42	suppressed
Amlodipine Besylate-Benazepril	Amlodipine Besylate/Benazepril	42	suppressed
Amoxicillin	Amoxicillin	42	28
Ozempic	Semaglutide	41	13
Azithromycin	Azithromycin	40	33
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	39	11
Montelukast Sodium	Montelukast Sodium	39	suppressed
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	38	11
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	37	11
Spironolactone	Spironolactone	36	suppressed
Acetaminophen-Codeine	Acetaminophen With Codeine	35	suppressed
Clopidogrel	Clopidogrel Bisulfate	35	suppressed
Bupropion Xl	Bupropion Hcl	34	11
Triamcinolone Acetonide	Triamcinolone Acetonide	33	17
Zolpidem Tartrate	Zolpidem Tartrate	31	suppressed
Fluoxetine Hcl	Fluoxetine Hcl	29	suppressed
Fluticasone Propionate	Fluticasone Propionate	29	13
Hydroxyzine Hcl	Hydroxyzine Hcl	29	suppressed
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	28	25
Mirtazapine	Mirtazapine	28	suppressed
Cephalexin	Cephalexin	27	24
Chlorthalidone	Chlorthalidone	27	suppressed
Finasteride	Finasteride	27	12
Lorazepam	Lorazepam	27	suppressed
Nitroglycerin	Nitroglycerin	27	19
Potassium Chloride	Potassium Chloride	27	suppressed
Breo Ellipta	Fluticasone/Vilanterol	25	suppressed
Doxazosin Mesylate	Doxazosin Mesylate	25	suppressed
Myrbetriq	Mirabegron	24	suppressed
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	24	suppressed
Glimepiride	Glimepiride	23	suppressed
Pramipexole Dihydrochloride	Pramipexole Di-Hcl	23	suppressed
Pioglitazone Hcl	Pioglitazone Hcl	22	suppressed
Tradjenta	Linagliptin	22	suppressed
Donepezil Hcl	Donepezil Hcl	21	suppressed
Mounjaro	Tirzepatide	21	suppressed
Nano 2nd Gen Pen Needle	Pen Needle, Diabetic	21	suppressed
Tizanidine Hcl	Tizanidine Hcl	21	suppressed
Amitriptyline Hcl	Amitriptyline Hcl	20	suppressed
Diazepam	Diazepam	20	suppressed
Alprazolam	Alprazolam	19	suppressed
Doxycycline Hyclate	Doxycycline Hyclate	19	17
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	19	12
Levetiracetam	Levetiracetam	19	suppressed
Diclofenac Sodium	Diclofenac Sodium	18	suppressed
Fenofibrate	Fenofibrate Nanocrystallized	18	suppressed
Solifenacin Succinate	Solifenacin Succinate	18	suppressed
Torsemide	Torsemide	18	suppressed
Trulicity	Dulaglutide	18	suppressed
Clonazepam	Clonazepam	17	suppressed
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	17	12
Olmesartan Medoxomil	Olmesartan Medoxomil	17	suppressed
Pregabalin	Pregabalin	17	suppressed
Bumetanide	Bumetanide	16	suppressed
Clonidine Hcl	Clonidine Hcl	16	suppressed
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	16	suppressed
Invokana	Canagliflozin	16	suppressed
Soliqua 100-33	Insulin Glargine/Lixisenatide	16	suppressed
Isosorbide Mononitrate Er	Isosorbide Mononitrate	15	suppressed
Nitrofurantoin Mono-Macro	Nitrofurantoin Monohyd/M-Cryst	15	12
Terazosin Hcl	Terazosin Hcl	15	suppressed
Venlafaxine Hcl Er	Venlafaxine Hcl	15	suppressed
Armour Thyroid	Thyroid,pork	14	suppressed
Bupropion Hcl Sr	Bupropion Hcl	14	suppressed
Celecoxib	Celecoxib	14	suppressed
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	14	suppressed
Divalproex Sodium	Divalproex Sodium	14	suppressed
Fenofibrate	Fenofibrate,micronized	14	suppressed
Hydromorphone Hcl	Hydromorphone Hcl	14	suppressed
Spiriva Respimat	Tiotropium Bromide	14	suppressed
Testosterone Cypionate	Testosterone Cypionate	14	suppressed
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	14	suppressed
Valsartan	Valsartan	14	suppressed
Colchicine	Colchicine	13	suppressed
Klor-Con 10	Potassium Chloride	13	suppressed
Valacyclovir	Valacyclovir Hcl	13	suppressed
Acyclovir	Acyclovir	12	suppressed
Aripiprazole	Aripiprazole	12	suppressed
Benazepril Hcl	Benazepril Hcl	12	suppressed
Cyanocobalamin Injection	Cyanocobalamin (Vitamin B-12)	12	suppressed
Diltiazem 24hr Er (Xr)	Diltiazem Hcl	12	suppressed
Estradiol	Estradiol	12	suppressed
Fenofibrate	Fenofibrate	12	suppressed
Gemfibrozil	Gemfibrozil	12	suppressed
Ketoconazole	Ketoconazole	12	suppressed
Memantine Hcl	Memantine Hcl	12	suppressed
Nystatin	Nystatin	12	suppressed
Primidone	Primidone	12	suppressed
Sulfamethoxazole-Trimethoprim	Sulfamethoxazole/Trimethoprim	12	11
Hydralazine Hcl	Hydralazine Hcl	11	suppressed
Hydrocodone Bitartrate Er	Hydrocodone Bitartrate	11	suppressed
Indomethacin	Indomethacin	11	suppressed
Lansoprazole	Lansoprazole	11	suppressed
Loperamide	Loperamide Hcl	11	suppressed
Lovastatin	Lovastatin	11	suppressed
Mesalamine	Mesalamine	11	suppressed
Ondansetron Hcl	Ondansetron Hcl	11	suppressed
Oxybutynin Chloride Er	Oxybutynin Chloride	11	suppressed
Paxlovid	Nirmatrelvir/Ritonavir	11	11
Propranolol Hcl Er	Propranolol Hcl	11	suppressed
Ropinirole Hcl	Ropinirole Hcl	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error